Krystal Biotech, Inc. (KRYS)
239.64
+5.00
(+2.13%)
USD |
NASDAQ |
Dec 10, 16:00
240.50
+0.86
(+0.36%)
After-Hours: 19:12
Krystal Biotech Market Cap: 6.949B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 53.41B |
| Vanda Pharmaceuticals, Inc. | 397.72M |
| ADMA Biologics, Inc. | 4.755B |
| Aldeyra Therapeutics, Inc. | 287.28M |
| ACADIA Pharmaceuticals, Inc. | 4.535B |
Market Cap Related Metrics
| PE Ratio | 35.94 |
| PS Ratio | 19.16 |
| PEG Ratio | 0.1297 |
| Price to Book Value | 6.107 |
| Price to Free Cash Flow | 43.18 |
| Price | 239.64 |
| Earnings Yield | 2.78% |
| PEGY Ratio | 0.1297 |
| Operating PE Ratio | 45.18 |
| Normalized PE Ratio | 35.94 |